메뉴 건너뛰기




Volumn 7, Issue 11, 2012, Pages

Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

EID: 84868700255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049091     Document Type: Article
Times cited : (36)

References (32)
  • 1
    • 46349111534 scopus 로고    scopus 로고
    • Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    • Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, et al. (2008) Changes in the risk of death after HIV seroconversion compared with mortality in the general population. Jama 300: 51-59.
    • (2008) Jama , vol.300 , pp. 51-59
    • Bhaskaran, K.1    Hamouda, O.2    Sannes, M.3    Boufassa, F.4    Johnson, A.M.5
  • 2
    • 21844465381 scopus 로고    scopus 로고
    • Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature
    • Ivers LC, Kendrick D, Doucette K, (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 41: 217-224.
    • (2005) Clin Infect Dis , vol.41 , pp. 217-224
    • Ivers, L.C.1    Kendrick, D.2    Doucette, K.3
  • 3
    • 58149085677 scopus 로고    scopus 로고
    • Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda
    • Abaasa AM, Todd J, Ekoru K, Kalyango JN, Levin J, et al. (2008) Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res 8: 241.
    • (2008) BMC Health Serv Res , vol.8 , pp. 241
    • Abaasa, A.M.1    Todd, J.2    Ekoru, K.3    Kalyango, J.N.4    Levin, J.5
  • 4
    • 0035876041 scopus 로고    scopus 로고
    • Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
    • Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, et al. (2001) Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids 15: 1181-1183.
    • (2001) Aids , vol.15 , pp. 1181-1183
    • Bangsberg, D.R.1    Perry, S.2    Charlebois, E.D.3    Clark, R.A.4    Roberston, M.5
  • 5
    • 77956536786 scopus 로고    scopus 로고
    • Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort
    • Ford N, Darder M, Spelman T, Maclean E, Mills E, et al. (2010) Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort. PLoS One 5: e10460.
    • (2010) PLoS One , vol.5
    • Ford, N.1    Darder, M.2    Spelman, T.3    Maclean, E.4    Mills, E.5
  • 6
    • 65449153627 scopus 로고    scopus 로고
    • The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
    • Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, et al. (2009) The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr 50: 529-536.
    • (2009) J Acquir Immune Defic Syndr , vol.50 , pp. 529-536
    • Lima, V.D.1    Harrigan, R.2    Bangsberg, D.R.3    Hogg, R.S.4    Gross, R.5
  • 7
    • 77952552600 scopus 로고    scopus 로고
    • World Health Organization Geneva: World Health Organization
    • World Health Organization (2003) Adherence to long-term therapy: Evidence for action. Geneva: World Health Organization. Available:http://apps.who.int/medicinedocs/en/d/Js4883e/.
    • (2003) Adherence to long-term therapy: Evidence for action
  • 8
    • 33845686172 scopus 로고    scopus 로고
    • HIV viral load monitoring in resource-limited regions: optional or necessary
    • Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, et al. (2007) HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis 44: 128-134.
    • (2007) Clin Infect Dis , vol.44 , pp. 128-134
    • Calmy, A.1    Ford, N.2    Hirschel, B.3    Reynolds, S.J.4    Lynen, L.5
  • 9
    • 72549119560 scopus 로고    scopus 로고
    • Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives
    • Harries AD, Zachariah R, van Oosterhout JJ, Reid SD, Hosseinipour MC, et al. (2010) Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis 10: 60-65.
    • (2010) Lancet Infect Dis , vol.10 , pp. 60-65
    • Harries, A.D.1    Zachariah, R.2    van Oosterhout, J.J.3    Reid, S.D.4    Hosseinipour, M.C.5
  • 10
    • 0042081457 scopus 로고    scopus 로고
    • Comment mesurer l'observance?
    • ANRS P, editor. L'observance aux traitements contre le VIH/sida: mesure, déterminants, évolution
    • Costagliola D, Barberousse C (2001) Comment mesurer l'observance? In: Collection sciences sociales et sida. ANRS P, editor. L'observance aux traitements contre le VIH/sida: mesure, déterminants, évolution. 33-42.
    • (2001) Collection sciences sociales et sida , pp. 33-42
    • Costagliola, D.1    Barberousse, C.2
  • 11
    • 0032796185 scopus 로고    scopus 로고
    • Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice
    • discussion 1073
    • Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21: 1074-90; discussion 1073.
    • (1999) Clin Ther , vol.21 , pp. 1074-1090
    • Farmer, K.C.1
  • 12
    • 0037114856 scopus 로고    scopus 로고
    • Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature
    • Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, et al. (2002) Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr 31 (Suppl 3):: S123-7.
    • (2002) J Acquir Immune Defic Syndr , vol.31 , Issue.SUPPL. 3
    • Ammassari, A.1    Trotta, M.P.2    Murri, R.3    Castelli, F.4    Narciso, P.5
  • 13
    • 79955013695 scopus 로고    scopus 로고
    • Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis
    • Bastard M, Fall MB, Laniece I, Taverne B, Desclaux A, et al. (2011) Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis. J Acquir Immune Defic Syndr 57: 55-61.
    • (2011) J Acquir Immune Defic Syndr , vol.57 , pp. 55-61
    • Bastard, M.1    Fall, M.B.2    Laniece, I.3    Taverne, B.4    Desclaux, A.5
  • 14
    • 33845286853 scopus 로고    scopus 로고
    • Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators
    • Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438.
    • (2006) PLoS Med , vol.3
    • Mills, E.J.1    Nachega, J.B.2    Bangsberg, D.R.3    Singh, S.4    Rachlis, B.5
  • 15
    • 81855183586 scopus 로고    scopus 로고
    • World Health Organization World Health Organization indicators to monitor HIV drug resistance prevention at antiretroviral treatment sites. Geneva: World Health Organization. Available
    • World Health Organization (2010) HIV drug resistance early warning indicators. World Health Organization indicators to monitor HIV drug resistance prevention at antiretroviral treatment sites. Geneva: World Health Organization. Available: http://www.who.int/hiv/topics/drugresistance/hiv_dr_early_warning_indicators.pdf.
    • (2010) HIV drug resistance early warning indicators
  • 16
    • 33646188761 scopus 로고    scopus 로고
    • Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment
    • Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367: 1335-1342.
    • (2006) Lancet , vol.367 , pp. 1335-1342
    • Ferradini, L.1    Jeannin, A.2    Pinoges, L.3    Izopet, J.4    Odhiambo, D.5
  • 17
    • 37349126951 scopus 로고    scopus 로고
    • Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
    • Ferradini L, Laureillard D, Prak N, Ngeth C, Fernandez M, et al. (2007) Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. Aids 21: 2293-2301.
    • (2007) Aids , vol.21 , pp. 2293-2301
    • Ferradini, L.1    Laureillard, D.2    Prak, N.3    Ngeth, C.4    Fernandez, M.5
  • 18
    • 67649848130 scopus 로고    scopus 로고
    • Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
    • Ahoua L, Guenther G, Pinoges L, Anguzu P, Chaix M-L, et al. (2009) Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. BMC infectious diseases 9: 81. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2701435&tool=pmcentrez&rendertype=abstract. Accessed 2012 April 25.
    • (2009) BMC infectious diseases , vol.9 , pp. 81
    • Ahoua, L.1    Guenther, G.2    Pinoges, L.3    Anguzu, P.4    Chaix, M.-L.5
  • 19
    • 79960663234 scopus 로고    scopus 로고
    • Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda
    • Ahoua L, Guenther G, Rouzioux C, Pinoges L, Anguzu P, et al. (2011) Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda. BMC pediatrics 11: 67. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3176156&tool=pmcentrez&rendertype=abstract. Accessed 2012 June 8.
    • (2011) BMC pediatrics , vol.11 , pp. 67
    • Ahoua, L.1    Guenther, G.2    Rouzioux, C.3    Pinoges, L.4    Anguzu, P.5
  • 20
    • 78651447800 scopus 로고    scopus 로고
    • Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia
    • Pujades-Rodríguez M, Schramm B, Som L, Nerrienet E, Narom P, et al. (2011) Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia. Tropical medicine & international health: TM & IH 16: 205-213. Available: http://www.ncbi.nlm.nih.gov/pubmed/21087376. Accessed 2012 June 8.
    • (2011) Tropical medicine & international health: TM & IH , vol.16 , pp. 205-213
    • Pujades-Rodríguez, M.1    Schramm, B.2    Som, L.3    Nerrienet, E.4    Narom, P.5
  • 21
    • 79960082310 scopus 로고    scopus 로고
    • World Health Organization Recommendations for a public health approach. 2010 revision. Geneva: World Health Organization
    • World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2010 revision. Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf.
    • (2010) Antiretroviral therapy for HIV infection in adults and adolescents
  • 22
    • 33646744181 scopus 로고    scopus 로고
    • Web resources for HIV type 1 genotypic-resistance test interpretation
    • Liu TF, Shafer RW, (2006) Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis 42: 1608-1618.
    • (2006) Clin Infect Dis , vol.42 , pp. 1608-1618
    • Liu, T.F.1    Shafer, R.W.2
  • 23
    • 33748879209 scopus 로고    scopus 로고
    • Rationale and uses of a public HIV drug-resistance database
    • Shafer RW, (2006) Rationale and uses of a public HIV drug-resistance database. J Infect Dis 194 (Suppl):: S51-8.
    • (2006) J Infect Dis , vol.194 , Issue.SUPPL.
    • Shafer, R.W.1
  • 24
    • 77954692661 scopus 로고    scopus 로고
    • Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries
    • Pujades-Rodriguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A, (2010) Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. Jama 304: 303-312.
    • (2010) Jama , vol.304 , pp. 303-312
    • Pujades-Rodriguez, M.1    Balkan, S.2    Arnould, L.3    Brinkhof, M.A.4    Calmy, A.5
  • 25
    • 33746902816 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis
    • Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Jama 296: 679-690.
    • (2006) Jama , vol.296 , pp. 679-690
    • Mills, E.J.1    Nachega, J.B.2    Buchan, I.3    Orbinski, J.4    Attaran, A.5
  • 28
    • 44449123557 scopus 로고    scopus 로고
    • Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
    • Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, et al. (2008) Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med 5: e109.
    • (2008) PLoS Med , vol.5
    • Bisson, G.P.1    Gross, R.2    Bellamy, S.3    Chittams, J.4    Hislop, M.5
  • 29
    • 78649754334 scopus 로고    scopus 로고
    • The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa
    • Brennan AT, Maskew M, Sanne I, Fox MP, (2010) The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa. J Int AIDS Soc 13: 49.
    • (2010) J Int AIDS Soc , vol.13 , pp. 49
    • Brennan, A.T.1    Maskew, M.2    Sanne, I.3    Fox, M.P.4
  • 30
    • 79952424135 scopus 로고    scopus 로고
    • Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa
    • El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, et al. (2011) Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One 6: e17518.
    • (2011) PLoS One , vol.6
    • El-Khatib, Z.1    Katzenstein, D.2    Marrone, G.3    Laher, F.4    Mohapi, L.5
  • 31
    • 77649288522 scopus 로고    scopus 로고
    • Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators
    • Ross-Degnan D, Pierre-Jacques M, Zhang F, Tadeg H, Gitau L, et al. (2010) Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res 10: 42.
    • (2010) BMC Health Serv Res , vol.10 , pp. 42
    • Ross-Degnan, D.1    Pierre-Jacques, M.2    Zhang, F.3    Tadeg, H.4    Gitau, L.5
  • 32
    • 34547692879 scopus 로고    scopus 로고
    • Body mass index cut offs to define thinness in children and adolescents: international survey
    • Cole TJ, Flegal KM, Nicholls D, Jackson AA, (2007) Body mass index cut offs to define thinness in children and adolescents: international survey. Bmj 335: 194.
    • (2007) Bmj , vol.335 , pp. 194
    • Cole, T.J.1    Flegal, K.M.2    Nicholls, D.3    Jackson, A.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.